Study: CBGA beneficial against epileptic seizures
Cannabis certainly helps, to treat epileptic seizures. But which molecule is involved, exactly? A study by Australian researchers, published in the British Journal of Pharmacology and peer-reviewed, provides a preliminary answer. «Three cannabinoids have anticonvulsant properties: cannabigerolic acid (CBGA), cannabidivaric acid, and cannabigerovaric acid», as shown by this study conducted on mice.
The researchers started with a very simple observation. It was thought that the CBD was the most potent cannabinoid for treating epilepsy, as evidenced by the development about the drug Epidiolex. But this treatment is rarely used, «often due to its high price, limited availability, and, in some cases, a preference for extracts" »full spectrum," the scientists note. «Artisanal products that have varied cannabinoid profiles and often low CBD concentrations. This suggests that other cannabinoids may contribute to the anticonvulsant properties.».
The scientists therefore used mice that also suffered from seizures, whether induced artificially or occurring naturally. Various cannabinoids were then administered: CBG, CBDV, CBGA, CBGV, and THCV.
«The CBGA is the most powerful»
The «winners» are indisputable: « Cannabidivarine (CBDV), cannabidivaric acid (CBDVA), CBGA, and cannabigerovaric acid (CBGVA) have demonstrated anticonvulsant properties and significantly raise the temperature threshold at which seizures begin.», according to Australian researchers.
The CBGA is even «Potentially more potent than CBD and deserves more attention for its anticonvulsant potential», the researchers recommend. However, the drug is by no means a magic solution. In fact, these seizures are induced artificially. In cases of spontaneous seizures, CBGA is not a solution and may even prove dangerous. However, when used in conjunction with clobazam—a medication already used to treat epilepsy—it has proven effective for spontaneous seizures.
In conclusion, « »It appears that CBGA is not as versatile as CBD as an anticonvulsant, even though it is more potent for seizures caused by hyperthermia.". According to the scientists who worked on this study, the cannabis-based anticonvulsant treatment «It doesn't start and end with CBD; other cannabinoids will need to be considered in the future.».
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe3 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in Ireland4 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Cannabis in the U.S.3 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Switzerland4 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project
-
Cannabis in France4 weeks ago
Reunion Island: The CBD Cannabis Cup Returns to Jardin Maniron on August 16, 2026
-
Business2 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon


You must be logged in to post a comment Login